A new proton accelerator, a superconducting cyclotron, has been put into operation for patient treatment. The accelerator is used in conjunction with a gantry, a device which delivers the protons to the patient from any angle. The desired dose distribution is achieved by scanning a small pencil beam of protons throughout the tumor. The performance of the new accelerator has been excellent since the start of medical operation.
Proton radiation therapy for deep seated tumors using a compact gantry with spot scanning technology was PSI’s unique contribution to particle radiotherapy worldwide. After 10 years of medical operation (over 260 patients were treated between 1996 and 2005) with PSI’s main accelerator as the beam source, we installed a dedicated proton accelerator for medical use. This relieved the medical program from yearly technical accelerator shut downs of several months and from limited beam availability per day and week, all of which were due to the complexity of a large research facility.
The dedicated proton accelerator (called the COMET) is a compact, superconducting 250 MeV cyclotron. The original design came from the National Superconducting Cyclotron Laboratory at Michigan State University and was adapted to PSI’s specifications and requirements. They included reliable all year round beam production for clinical operation of both the original gantry (Gantry 1) and the eye treatment facility as well as technical flexibilities to accommodate the next generation gantry which features advanced beam scanning and is presently under construction (Gantry 2). Gantry 2 is a further PSI development which will bring beam scanning to the forefront of the medical use of protons.
The cyclotron was fabricated by ACCEL Instruments GmbH (Varian) in Bergisch Gladbach, Germany, and was successfully installed, commissioned and connected to Gantry 1 in 2006/7. The collaboration between ACCEL and PSI resulted in a system that meets stringent specifications, including reliability and efficient maintenance. The technical performance of the cyclotron has met all expectations and the first patient was treated with Gantry 1 and COMET in February 2007. After a planned shut down for technical fine tuning between June and early August patient treatments have been resumed. Future medical operation will be year round.
Gantry 2, with advanced beam scanning and features allowing the treatment of moving targets, will be commissioned in 2008. It is anticipated that the sophisticated technology of COMET and Gantry 2 will determine the future state-of-the-art of proton radiation therapy. Technology transfer to industry and clinics who are interested in advanced proton therapy facilities is foreseen.
Martin Jermann | alfa
Visualizing gene expression with MRI
23.12.2016 | California Institute of Technology
Illuminating cancer: Researchers invent a pH threshold sensor to improve cancer surgery
21.12.2016 | UT Southwestern Medical Center
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
20.01.2017 | Awards Funding
20.01.2017 | Materials Sciences
20.01.2017 | Life Sciences